TAP deficiency syndrome.
Institute of Molecular Medicine, Nuffield Department of Medicine, Oxford, UK.
S D
SD
Gadola
H T
HT
Moins-Teisserenc
J
J
Trowsdale
W L
WL
Gross
V
V
Cerundolo
D000071181:ATP Binding Cassette Transporter, Subfamily B, Member 2; D000071450:ATP Binding Cassette Transporter, Subfamily B, Member 3; D018528:ATP-Binding Cassette Transporters / Q000737:chemistry / Q000235:genetics / Q000502:physiology*; D017951:Antigen Presentation; D001692:Biological Transport; D001987:Bronchiectasis / Q000209:etiology; D002648:Child; D002675:Child, Preschool; D003937:Diagnosis, Differential; D019281:Dimerization; D020022:Genetic Predisposition to Disease; D006099:Granuloma / Q000209:etiology / Q000473:pathology; D006680:HLA Antigens / Q000276:immunology / Q000378:metabolism; D006801:Humans; D016867:Immunocompromised Host; D007153:Immunologic Deficiency Syndromes / Q000175:diagnosis; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007223:Infant; D007239:Infections / Q000209:etiology; D007372:Interferons / Q000627:therapeutic use; D008285:Major Histocompatibility Complex; D009336:Necrosis; D010641:Phenotype; D010778:Photochemotherapy; D012507:Sarcoidosis / Q000175:diagnosis; D016511:Severe Combined Immunodeficiency / Q000145:classification / Q000175:diagnosis / Q000235:genetics* / Q000276:immunology / Q000628:therapy; D012871:Skin Diseases / Q000209:etiology / Q000473:pathology; D012883:Skin Ulcer / Q000209:etiology / Q000628:therapy; D013577:Syndrome
D000071181:ATP Binding Cassette Transporter, Subfamily B, Member 2; D000071450:ATP Binding Cassette Transporter, Subfamily B, Member 3; D018528:ATP-Binding Cassette Transporters; D006680:HLA Antigens; D007166:Immunosuppressive Agents; C073119:TAP1 protein, human; C071692:TAP2 protein, human; D007372:Interferons